Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 4Other neoplasm 3Gastrointestinal 3CNS 3Sarcoma 2Other solid neoplasm 2Lymphoid 2Genitourinary 2Dermatologic 2Breast 2Other hematologic neoplasm 1Head & Neck 1Gynecologic 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 1Leukemia 1Congenital Abnormalities 1

Interventions

Cytarabine 905Cyclophosphamide 899fludarabine 525venetoclax 489fludarabine phosphate 468Azacitidine 460Rituximab 431Methotrexate 419Etoposide 320Filgrastim 299Busulfan 296Dexamethasone 286Vincristine 285Daunorubicin 283Peripheral Blood Stem Cell Transplantation 258Whole-Body Irradiation 243Mycophenolic Acid 232Decitabine 230Granulocyte Colony-Stimulating Factor 227Tacrolimus 220Imatinib Mesylate 211Idarubicin 205Melphalan 202Cyclosporine 182Doxorubicin 177Radiotherapy 169Prednisone 164Dasatinib 163Mitoxantrone 161Lenalidomide 160

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Comparative Genomic Hybridization × Other hematologic neoplasm × Clear all
NCT00897936 2020-07-31

DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia

Eastern Cooperative Oncology Group

Completed
418 enrolled
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡